DarioHealth Corp. (DRIO) |
| 4.6 -0.22 (-4.56%) 10-19 15:25 |
| Open: | 5.3154 |
| High: | 5.3154 |
| Low: | 4.48 |
| Volume: | 20,652 |
| Market Cap: | 45(M) |
| PE Ratio: | -0.78 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 7.20 |
| Resistance 1: | 6.16 |
| Pivot price: | 5.73 |
| Support 1: | 4.48 |
| Support 2: | 3.73 |
| 52w High: | 17.74 |
| 52w Low: | 4.5 |
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they offer comprehensive diabetes management programs that integrate lifestyle changes, healthy eating guidance, advanced tracking tools, and live coaching. Founded in 2011, the company was formerly known as LabStyle Innovations Corp. before officially changing its name to DarioHealth Corp. in July 2016. Its headquarters are located in New York, New York.
| EPS | -2.280 |
| Book Value | 7.500 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.319 |
| Profit Margin (%) | -169.87 |
| Operating Margin (%) | -125.15 |
| Return on Assets (ttm) | -19.4 |
| Return on Equity (ttm) | -59.9 |
Tue, 13 Oct 2026
DarioHealth (DRIO) Edges Lower to $5.45 as Traders Watch Key Support Zone - Gap Up Stocks - dars.gov.et
Tue, 06 Oct 2026
DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs - PR Newswire
Mon, 28 Sep 2026
DarioHealth (DRIO) director Karah Hila holds 58,965 shares after a restricted share award. - Stock Titan
Mon, 28 Sep 2026
DarioHealth (DRIO) director John R. Palumbo receives shares that vest after two years - Stock Titan
Mon, 31 Aug 2026
DarioHealth Corp. (DRIO) Gains 2.07% as Shares Test Key Resistance Zone - Sign of Strength - siam.in
Fri, 14 Aug 2026
Analysts Have Made A Financial Statement On DarioHealth Corp.'s (NASDAQ:DRIO) Second-Quarter Report - Simply Wall Street
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |